These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 1676326)

  • 1. PROMISE results slam milrinone.
    Br J Hosp Med; 1991 Apr; 45(4):233. PubMed ID: 1676326
    [No Abstract]   [Full Text] [Related]  

  • 2. Milrinone: a positive inotropic vasodilator.
    Colucci WS; Jaski BE; Fifer MA; Wright RF; Braunwald E
    Trans Assoc Am Physicians; 1984; 97():124-33. PubMed ID: 6535335
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of milrinone on ventricular arrhythmias in congestive heart failure.
    Ferrick KJ; Fein SA; Ferrick AM; Doyle JT
    Am J Cardiol; 1990 Aug; 66(4):431-4. PubMed ID: 2386119
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group.
    Packer M; Carver JR; Rodeheffer RJ; Ivanhoe RJ; DiBianco R; Zeldis SM; Hendrix GH; Bommer WJ; Elkayam U; Kukin ML
    N Engl J Med; 1991 Nov; 325(21):1468-75. PubMed ID: 1944425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Milrinone, a new agent for the treatment of congestive heart failure.
    Hasegawa GR
    Clin Pharm; 1986 Mar; 5(3):201-5. PubMed ID: 3514085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inotropic therapy for heart failure--an unfulfilled promise.
    Curfman GD
    N Engl J Med; 1991 Nov; 325(21):1509-10. PubMed ID: 1944430
    [No Abstract]   [Full Text] [Related]  

  • 7. A comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure.
    DiBianco R; Shabetai R; Kostuk W; Moran J; Schlant RC; Wright R
    N Engl J Med; 1989 Mar; 320(11):677-83. PubMed ID: 2646536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Canadian multicentre study of a 48 h infusion of milrinone in patients with severe heart failure.
    Pflugfelder PW; O'Neill BJ; Ogilvie RI; Beanlands DS; Tanser PH; Tihal H; Mizgala HF; Fitchett DH; Kostuk WJ
    Can J Cardiol; 1991; 7(1):5-10. PubMed ID: 2025794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term intravenous milrinone for severe congestive heart failure: the good, bad, and not so good.
    Varriale P; Ramaprasad S
    Pharmacotherapy; 1997; 17(2):371-4. PubMed ID: 9085331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New positive inotropic drugs in the treatment of congestive heart failure.
    Kennedy GT
    Prog Cardiovasc Nurs; 1987; 2(3):100-4. PubMed ID: 2959954
    [No Abstract]   [Full Text] [Related]  

  • 11. [Inotropic agents in the treatment of congestive heart failure].
    Iizuka M
    Jpn Circ J; 1993; 57 Suppl 4():1363-6. PubMed ID: 7966987
    [No Abstract]   [Full Text] [Related]  

  • 12. Oral milrinone in severe chronic heart failure.
    Feldman AM; Baughman KL; Strobeck JE
    N Engl J Med; 1992 Jun; 326(23):1565-6; author reply 1567. PubMed ID: 1579142
    [No Abstract]   [Full Text] [Related]  

  • 13. Enoximone and milrinone--inotropic vasodilators for severe heart failure.
    Drug Ther Bull; 1991 May; 29(10):39-40. PubMed ID: 1834448
    [No Abstract]   [Full Text] [Related]  

  • 14. Milrinone. A preliminary review of its pharmacological properties and therapeutic use.
    Young RA; Ward A
    Drugs; 1988 Aug; 36(2):158-92. PubMed ID: 3053125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral milrinone in severe chronic heart failure.
    Desjardins S
    N Engl J Med; 1992 Jun; 326(23):1565; author reply 1567. PubMed ID: 1579141
    [No Abstract]   [Full Text] [Related]  

  • 16. [Value of the use of milrinone in the treatment of acute crisis in patients with congestive heart failure].
    Gun C; Piegas LS; Bianco AC; Freire RB; Ramos RF; Timerman A
    Arq Bras Cardiol; 1995 Sep; 65(3):255-8. PubMed ID: 8579514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe heart failure: balancing length and quality of life.
    Harv Heart Lett; 1999 Jun; 9(10):1-2. PubMed ID: 10233785
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of milrinone on steady-state digoxin levels in congestive heart failure.
    Ferrick KJ; Ferrick AM; Fein SA; Doyle JT
    Am J Cardiol; 1989 Nov; 64(16):1057. PubMed ID: 2816742
    [No Abstract]   [Full Text] [Related]  

  • 19. Chronic heart failure and the quality of life.
    Pritzker MR
    N Engl J Med; 1999 May; 340(19):1511; author reply 1512. PubMed ID: 10328720
    [No Abstract]   [Full Text] [Related]  

  • 20. The inotropic and hemodynamic effects of intravenous milrinone when reflex adrenergic stimulation is suppressed by beta-adrenergic blockade.
    Travill CM; Pugh S; Noble MI
    Clin Ther; 1994; 16(5):783-92. PubMed ID: 7859237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.